CLL Treatment Journey

Video Library published on December 7, 2022 in CAPE CLL
Nikki Barkett, BSN, RN, OCN
Oral Antineoplastics Nurse Navigator
Banner University of Arizona Cancer Center
Tucson, AZ

Our CLL clinical advisor dives into the different targeted therapies for CLL patients including oral oncolytics and the impact navigation has on adherence to treatment and the multidisciplinary approach to care.

Related Items
Overview of Chronic Lymphocytic Leukemia (CLL)
Chelsea Passwater, DNP, RN, AGCNS-BC, OCN
Video Library published on December 7, 2022 in CAPE CLL
Watch as our CLL clinical advisor dives deeper into defining CLL, the clinical staging systems developed for this disease, and the role navigators play in the patient’s treatment journey.
Learn More
CLL: Watch and Wait Period
Nikki Barkett, BSN, RN, OCN
Video Library published on December 7, 2022 in CAPE CLL
Listen in as our CLL clinical advisor examines the “Watch and Wait” period in CLL and impact navigation can have during this period.
Learn More
The Role of Genetics in CLL
Chelsea Passwater, DNP, RN, AGCNS-BC, OCN
Video Library published on December 7, 2022 in CAPE CLL
A look at understanding the complexities of mutations and cytogenetics in CLL, the role genetics plays in prognosis, and how navigators can educate their patients and caregivers.
Learn More

Back to Top

 

ASSOCIATION

 

MEMBERSHIP

 
Conquer April 2024 Vol 10, No 2
Conquer Logo
Visit the Website
JONS
JONS Logo
Visit the Website

Privacy Notice   |   Terms of Use
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators®   |   PO Box 563, Cranbury, NJ 08512   |    This email address is being protected from spambots. You need JavaScript enabled to view it.   |    732-992-1532
AONN+ DBA AONN+ is a 501(c)(6) organization under federal tax guidelines. AONN+ Foundation for Learning, Inc. a 501(c)(3) organization under federal tax guidelines.
AONN+ Advantage, LLC, a wholly owned subsidiary of AONN+.